Navigation Links
IDE Technologies Signs Contract Worth Over 100 Million Euros to Supply a Desalination Plant to Australia

IDE CEO: "This Deal Places IDE in a Key Position for Competing for Similar

Projects in the Future, Establishes IDE's Presence on the Australian

Continent and Strengthens its Worldwide Deployment

TEL AVIV, Israel, August 12 /PRNewswire/ -- IDE Technologies, jointly owned (50:50) by The Israel Corporation Group subsidiary Israel Chemicals and the Delek Group, signed a contract to supply a desalination plant worth over a 100 million Euros to a major industrial client in Australia. The client will use the desalinated water for its production processes.

Slated for completion during 2010, the new plant will be based on reverse osmosis technology - a modern process technology used for desalinating water in a wide range of applications. The plant will provide 140,000 cubic meters/day (50 million cubic meters/year) of high quality desalinated process and drinking water, using innovative technologies implemented by IDE in its projects worldwide, for example in the plants in Ashkelon and Hadera (over 100 million cubic meters/year each), Cyprus (20 million cubic meters /year) and in Eilat (3.6 million cubic meters/year).

This project is one of the most complex in the world and one of the largest of its kind supplied by IDE to a foreign client. The quality of the feed water necessitates more precise and complex treatment than in similar installations elsewhere and will be subject to the rigid and meticulous standards of the local industry.

Avshalom Felber, Chief Executive Officer of IDE, welcomed the signing, calling the deal "one of the most challenging the company has known, which places IDE in a key position for competing for similar projects in the future. It establishes IDE's presence on the Australian continent strengthens its worldwide deployment in line with the company's business strategy of global expansion and strengthens IDE's position as a world leader in the seawater desalination market."

About IDE Technologies

Established in 1965, IDE Technologies is a world leader in water desalination. Jointly owned (50% each) by Israel Chemicals and the Delek Group, it specializes in commercial applications of thermal and membrane technologies for desalinating and converting sea- and brackish water to drinking and process water. Since its establishment the company has supplied more than 385 plants of different types and capacities, which supply high quality desalinated water to industries, mines, refineries, power stations and for urban and agricultural use. Spanning 40 countries on all continents, IDE's plants produce more than 1,600,000 cubic meters /day.


Mr. Henri Inzelberg

VP Marketing

IDE Technologies Ltd

t: +972-9-892-9791

SOURCE IDE Technologies Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. China Medical Technologies Announces Concurrent Offerings of $150 Million of Convertible Senior Notes and Purchased ADSs Pursuant to ADS Issuance and Repurchase Agreements
2. Free White Paper: Hospital Tests Patient Lift Technologies; Improves Quality of Care
3. Wound Management Technologies, Inc. Announces Products to Be Registered in Taiwan
4. On-X Life Technologies Significantly Reduces Study Management Costs with TEMPO from Clinipace
5. VNUS Medical Technologies Reports Second-Quarter 2008 Results: 25% Growth in Net Product Revenues and 38% Growth in Unit Sales
6. Palomar Medical Technologies to Host Second Quarter 2008 Financial Results Conference Call and Webcast on July 31, 2008
7. SeQual Technologies, American Lung Association of California and Seton Medical Center Partner to Support Survivor & Cyclist in 500-Mile California Ride
8. China Medical Technologies to Announce Financial Results for the First Quarter Ended June 30, 2008 on August 4, 2008
9. Realtime Technologies Launches SHIMMER - a Wearable Health Sensor for Both Connected and Wireless Environments
10. Dilon Technologies Signs Amerinet for Breast-Specific Gamma Imaging
11. Wound Management Technologies, Inc. Announces Filing of a 510K
Post Your Comments:
(Date:6/24/2016)... ... 2016 , ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida ... their peers for this recognition are considered among the top 2 percent of lawyers ... as members of this year’s Legal Elite Hall of Fame: Miami Shareholders Mark ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... Comfort ... the American Cancer Society and the Road To Recovery® program to drive cancer patients ... seniors and other adults to ensure the highest quality of life and ongoing independence. ...
(Date:6/24/2016)... ... ... People across the U.S. are sharpening their pencils and honing their writing skills ... patients and their families pay tribute to a genetic counselor by nominating him or ... Counselors (NSGC) Annual Education Conference (AEC) this September. , In April, Genome magazine ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... proud to recognize Dr. Barry M. Weintraub as a prominent plastic surgeon and ... women in the world, and the most handsome men, look naturally attractive. Plastic ...
(Date:6/24/2016)... ... June 24, 2016 , ... Strategic Capital Partners, LLC (SCP) ... obtaining investment capital for emerging technology companies. SCP has delivered investment events ... in more than a million dollars of capital investment for five companies. ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Research and Markets has announced the addition of ... report to their offering. ... The World Market for Companion Diagnostics covers the world market ... the report includes the following: , World ... Region (N. America, EU, ROW), 2015-2020 , World IVD ...
(Date:6/23/2016)... HOUSTON , June 23, 2016  MedSource ... platform as its e-clinical software solution of choice.  ... the best possible value to their clients by ... nowEDC.  The preferred relationship establishes nowEDC as the ... pricing for MedSource,s full-service clients.  "nowEDC has long ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that it ... (procalcitonin) assay as a dedicated testing solution for people ... Roche is the first IVD company in the U.S ... assessment and management. PCT is a sepsis-specific ... blood can aid clinicians in assessing the risk of ...
Breaking Medicine Technology: